Director’s Blog Imagine for a moment that we had the magic bullet for depression or schizophrenia or anorexia or autism. A single pill, taken once a day, safe and effective, that would immediately and continually keep all of the symptoms at bay.

Read >

Just returning from the World Economic Forum (WEF) in Davos, Switzerland. While media reports covered speeches from some of the 40 heads of state attending or skewered the over-the-top parties of the rich and famous associated with this annual meeting, they missed a remarkable story: this was the year that mental health became a hot topic at the WEF.

Read >

Director’s Blog Today, on World Suicide Prevention Awareness Day, an updated National Strategy for Suicide Prevention is being released amidst a public health landscape that has changed thanks in part to the focus brought to suicide by the first national strategy issued 11 years ago. Since the first version was issued, the Suicide Prevention Lifeline was established, Federal and State legislation has been passed that advances suicide prevention planning and programming, and the Suicide Prevention Resource Center was established, among other efforts.

Read >

Director’s Blog One of the most influential trials in cardiology over the past 25 years was the GISSI 1 study, which demonstrated the beneficial effects of administering a medication called streptokinase after a heart attack. 2 GISSI involved more than 11, 000 patients in 176 coronary care units over 17 months. Its total cost was less than $500, 000.

Read >